A solid-phase enzyme immunoassay method for the measurement of total and class-specific serum antibodies to Campylobacterjejuni was developed. The test was found to be both sensitive and specific. Immunoglobulin M, G, and A antibodies were detected in about 90% of sera collected from patients recovering from Campylobacter enteritis, with the pattern of appearance and decline of these antibodies conforming to that usually seen in an acute infection. A poor antibody response was noted in patients with intermittent or prolonged enteritis. The clinical implications and diagnostic value of this test are discussed.
Since 1946, when Levy (12) first reported the recovery of vibrio-like organisms from the blood of patients with enteritis, a number of reports implicating Campylobacterjejuni as a causative agent of human enteritis have been published (6, 7, 14, 18) . Despite this, the source and epidemiology of Campylobacter enteritis remain largely obscure (1, 8, 13 ). The disease is usually selflimiting-few patients require antibiotic therapy, and only a small number suffer from intermittent diarrhea or become asymptomatic carriers. The occasional isolation of C. jejuni together with other enteric pathogens from feces of patients with enteritis (3, 7, 13) raises the possibility of C. jejuni acting as an opportunistic pathogen or as a passive partner to some other trigger species (in a manner similar to its association with Treponema hyodysenteriae) in cases of swine dysentery (15) .
To clarify the pathogenicity of C. jejuni, a more detailed study of the immune response to Campylobacter enteritis was needed. To date, several workers have reported the use of bacterial agglutination (14) , hemagglutination (5), a fluorescent antibody technique (3, 4) , and a complement fixation test (10) to demonstrate the existence of specific antibodies to C. jejuni.
These studies examined only a very limited number of patients and in some instances failed to detect the presence of specific antibody (5, 9) . (ii) Control sera. A total of 26 serum samples were collected from 24 patients suffering from enteritis from whom specific pathogens other than C. jejuni were recovered (18 patients with salmonellosis, 5 with shigellosis, and 1 with cholera). The duration of disease in this group of patients broadly matched that of the patients with Campylobacter enteritis. Twenty-seven serum samples were collected from 25 members of the Department of Clinical Pathology of Fairfield Hospital. All specimens used for this study were portions of samples collected for routine hematological or biochemical tests.
Antigen preparation. A pool of six strains of C. jejuni was used for the preparation of the antigen. All of these strains were identified as belonging to serotype C (using the serological scheme based on recognition of heat-stable somatic antigens [2] of bovine serum albumin to block any remaining uncoated areas of the plastic surface was investigated; however, because this procedure provided no improvement in the specificity of the test, it was discontinued.
Basically, the test was divided into two parts: (i) Screening procedure. To screen for antibody titers above those found in the normal population, 50-pul amounts of test serum diluted 1:40 in phosphatebuffered saline were delivered in triplicate into the precoated test wells and uncoated control wells. After incubation at 37°C for 90 min, the plates were washed nine times with a solution of phosphate-buffered saline containing 0.5% Tween 20. Fifty microliters of an appropriate dilution of peroxidase-conjugated antihuman immunoglobulin (DAKO-Immunoglobulins Ltd., Copenhagen, Denmark) was added, and the plates were incubated for 90 min at 37°C. After six washes with phosphate-buffered saline-0.5% Tween 20, 50 p.l of substrate color indicator (2 ml of a 0.1% methanolic solution of o-phenylenediamine and 300 p.l of hydrogen peroxide in 100 ml of distilled water) was added. The plates were incubated at room temperature in the dark for 30 min, after which the reaction was stopped by the addition of 50 pJ1 of 4 N sulfuric acid. A presumptive positive result was recorded for those sera for which the color of the test wells was markedly stronger than the color of the serum control wells (i.e., with an absorbance at least 1.25 times that of the control), and a titration of class-specific immunoglobulins was performed. With each run, positive and negative sera were included for comparison.
(ii) Titration of class-specific antibodies. For titration of class-specific antibodies, the screening procedure was modified as follows. Doubling dilutions of 1:40 prediluted sera were made in the microtiter plates, and class-specific peroxidase-conjugated antihuman immunoglobulins (IgM, IgG, and IgA) were used. The endpoint of the reaction was regarded as the last dilution with a color intensity greater than or equal to that of the 1:40 dilution of the serum control, which was tested in triplicate. Although it is desirable to read the color intensity on a colorimeter, reading by visual comparison of the test and control wells was found to be satisfactory.
The specificity of the procedure was confirmed by eliciting an inhibition of the reaction with specific rabbit anti-Campylobacter antiserum and by the failure of other enteric pathogens (Salmonella tvphimuriiam, Shigella flexneri, and Vibrio cholerae) to absorb out specific antibody from the test sera.
RESULTS
The serum antibody titers of IgM, IgG, and IgA in the Campylobacter enteritis group and in the normal control and gastroenteritis control groups are presented in Fig. 1 . In the normal control group, the titers of IgM and IgA were all 80 or less and IgG titers were 320 or less. Similar titers were found in the gastroenteritis control group. Specimens from patients with Campylobacter enteritis were examined in relation to time of collection after onset of illness. The first set of sera consisted of those collected in the initial stages of the illness, within 7 days of the onset of symptoms. The second set was composed of sera collected 8 or more days after the onset of symptoms.
When patients with Campylobacter enteritis were subdivided in relation to illness duration (Table 1) , detectable levels of serum antibodies were present in 59% of patients' sera 6 or 7 days after the onset of illness, and in 79% of patients' sera 10 or more days after onset. However, when asymptomatic carriers and patients suffering from intermittent diarrhea were excluded, the percentage of patients with specific antibodies increased to 96.
Follow-up serum samples were available for 33 patients; antibody titers for 5 of these are presented in Table 2 to illustrate the early and late responses to infection. The titers of all classes of specific immunoglobulins in these patients rose within 10 days of the onset of symptoms, with IgM-and IgA-specific antibody titers declining rapidly 1 week later. IgG levels, which peaked about 2 weeks after the onset of symptoms, began to decline after 3 or more weeks; however, high levels of IgG persisted for several months in some patients.
Of 21 serum samples from 14 patients with fecal excretion of C. jejuni who were either asymptomatic carriers or suffering from intermittent diarrhea, only 8 were found to have slight but significant increases in specific immunoglobulin levels. The remaining sera from these patients had specific immunoglobulin of -80 and are included in the group of C. jejuni enteritis sera collected 8 or more days after the onset of symptoms (see Fig. 1 ). Contrary to the findings for adult patients, there was no notable increase in specific serum IgA levels in specimens from infants with Campylobacter enteritis.
DISCUSSION
The enzyme-linked immunosorbent assay has been shown to be a sensitive, specific, and reliable technique for the detection of specific Campylobacter antibodies. Of patients with culture-positive Campylobacter enteritis, 80 to 90% had detectable levels of specific serum immunoglobulins to C. jejuni, with the noted appearance and decline of antibodies confirming to the pattern found in other infectious diseases. These findings further clarify the pathogenicity of C. jejuni to humans.
High levels of IgG-specific antibodies tend to persist in patients with Campylobacter enteritis and are higher than the levels of either IgM or IgA in the normal control group. Although these findings indicate that the estimation of IgGspecific antibodies would be unsuitable for the diagnosis of recent infection with C. jejuni, they do point to the value of such testing in a study of the prevalence of C. jejuni enteritis in the general community. Conversely, the detection of raised titers of either IgA-or IgM-specific antibodies (a primary immune response) would indicate recent infection with C. jejuni, for titers of these antibodies rapidly decline to normal levels after 2 weeks from the onset of symptoms.
High levels of IgA-specific antibodies were detected in the sera of some patients with Campylobacter enteritis. We can only speculate that a large infective dose has caused additional IgA antibodies produced by the local plasma cells to enter the lymphatics as serum IgA (17) . The detection of very low levels of specific IgA antibody in the serum of young children is probably due to their immature immunological IgA status.
Specific antibodies were not found in the majority of patients with chronic or intermittent diarrhea attributed to C. jejuni. A possible explanation is that the immune systems of these patients fail to recognize the species as a pathogen due to the milder nature of their illnesses. This inability to mount an immune response to infection with C. jejuni could also explain the failure of other workers to detect specific serum antibodies (5, 9) and the reported incidence of relapse in some patients (5, 7, 11) . The absence of specific serum antibodies to C. jejuni 2 weeks after the onset of symptoms could be used to pinpoint those patients who are potential candidates for relapse or the development of intermittent diarrbea and for whom antibiotic therapy is therefore warranted.
The increased specific immunoglobulin levels in one patient in the enteritis control group may have resulted from a mixed bacterial infection, despite negative cultures for C. jejuni. The incidence of the implication of more than one bacterial pathogen in gastroenteritis is reportedly high (3, 7, 16) .
In a situation where the early administration of antibiotic therapy or a delay in the collection of samples has prevented the isolation of C. jejuni from a case of bacterial enteritis, confirmation of the causative species and distinction between recent infection and past infection are made possible by the estimation of specific serum antibodies.
